Results for tag: "Vilanterol"

Vilanterol is a long-acting beta-2 agonist (LABA) drug used in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it helps to open up the airways in the lungs, making it easier to breathe. Vilanterol is usually taken in combination with an inhaled corticosteroid (ICS) to provide long-term control of symptoms. It is available in both metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). The Vilanterol market is a growing segment of the respiratory drugs market. It is used to treat a wide range of respiratory diseases, including asthma, COPD, and other chronic respiratory conditions. Vilanterol is a relatively new drug, and its use is increasing as more people are diagnosed with respiratory diseases. The Vilanterol market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more